AF
MRTX

Allworth Financial’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Allworth Financial’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-107
Closed -$6.29K – 3715
2023
Q4 		$6.29K Buy
107
+27
+34% +$1.52K ﹤0.01% 2175
2023
Q3 		$3.48K Buy
+80
New +$2.86K ﹤0.01% 2290
2023
Q2 		– Sell
-22
Closed -$818 – 3419
2023
Q1 		$818 Buy
+22
New +$990 ﹤0.01% 2742
2022
Q4 		– Sell
-6
Closed – – 3246
2022
Q3 		$0 Sell
6
-148
-96% -$11K ﹤0.01% 3203
2022
Q2 		$10K Buy
+154
New +$9.79K ﹤0.01% 1583
2021
Q4 		– Sell
-70
Closed -$12K – 2170
2021
Q3 		$12K Buy
+70
New +$11.3K ﹤0.01% 1254

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Allworth Financial's MRTX Position: Q1 2024 in Review

Allworth Financial sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 107 shares — an estimated $6.29K sold.

Allworth Financial first reported a position in MRTX in Q3 2021 and held it in 6 quarters. The position peaked at $12K in Q3 2021. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Allworth Financial reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Allworth Financial sold 107 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $6.29K.
  • Allworth Financial first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2021 and held it in 6 quarters.
  • Allworth Financial's Mirati Therapeutics, Inc. Common Stock position peaked at $12K in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Allworth Financial's 13F filing for Q1 2024, filed 25 Apr 2024.